Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients
Condition(s):Dyspepsia; Biliary DysplasiaLast Updated:March 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Dyspepsia; Biliary DysplasiaLast Updated:March 22, 2022Completed
Condition(s):Dyspepsia; Functional Gastrointestinal Disorders; Antidepressant Discontinuation Syndrome; Antidepressant Drug Adverse ReactionLast Updated:March 31, 2022Unknown status
Condition(s):Therapeutic Mechanism of Antidepressants for Refractory FDLast Updated:June 4, 2019Unknown status
Condition(s):Functional Gastrointestinal DisorderLast Updated:September 16, 2016Completed
Condition(s):Functional Gastrointestinal Disorders; Dyspepsia; Psychosomatic DisorderLast Updated:August 10, 2022Recruiting
Condition(s):DyspepsiaLast Updated:March 5, 2021Terminated
Condition(s):Functional DyspepsiaLast Updated:October 1, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.